Gustav Steinhoff
Overview
Explore the profile of Gustav Steinhoff including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
161
Citations
2808
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Sasse S, Skorska A, Lux C, Steinhoff G, David R, Gaebel R
Cells
. 2020 Jan;
9(1).
PMID: 31892273
Background: Bone marrow (BM)-derived stem cells with their various functions and characteristics have become a well-recognized source for the cell-based therapies. However, knowledge on their therapeutic potential and the shortage...
12.
Vasudevan P, Gaebel R, Doering P, Mueller P, Lemcke H, Stenzel J, et al.
Cells
. 2019 Dec;
8(12).
PMID: 31835854
Cellular inflammation following acute myocardial infarction has gained increasing importance as a target mechanism for therapeutic approaches. We sought to investigate the effect of syngeneic cardiac induced cells (CiC) on...
13.
Sadraddin H, Gaebel R, Skorska A, Lux C, Sasse S, Ahmad B, et al.
Cells
. 2019 Nov;
8(12).
PMID: 31757119
Background: Ventricular arrhythmias (VA) are a common cause of sudden death after myocardial infarction (MI). Therefore, developing new therapeutic methods for the prevention and treatment of VA is of prime...
14.
Ayyat K, Argawi A, Mende M, Steinhoff G, Borger M, Deebis A, et al.
Ann Thorac Surg
. 2019 Aug;
108(6):1913-1921.
PMID: 31398356
Background: Although the safety and feasibility of combined coronary artery bypass grafting (CABG) and bone marrow stem cell (BMSC) transplantation have been proven, the efficacy of this approach remains controversial....
15.
Thiele F, Voelkner C, Krebs V, Muller P, Jung J, Rimmbach C, et al.
Cell Physiol Biochem
. 2019 Aug;
53(2):337-354.
PMID: 31373783
Background/aims: The availability of truly maturated cardiomyocytic subtypes is a major prerequisite for cardiovascular cell replacement therapies. Pluripotent stem cells provide a suitable source for the development of new strategies...
16.
Liu Y, Niu R, Li W, Lin J, Stamm C, Steinhoff G, et al.
Cell Mol Life Sci
. 2019 Feb;
76(9):1681-1695.
PMID: 30721319
Despite significant developments in medical and surgical strategies, cardiac diseases remain the leading causes of morbidity and mortality worldwide. Numerous studies involving preclinical and clinical trials have confirmed that stem...
17.
Klopsch C, Gaebel R, Lemcke H, Beyer M, Vasudevan P, Fang H, et al.
Cells Tissues Organs
. 2019 Jan;
206(1-2):35-45.
PMID: 30630170
In-depth knowledge of the mechanisms induced by early postischemic cardiac endogenous mesenchymal stem cells (MSCs) in the acutely ischemic heart could advance our understanding of cardiac regeneration. Herein, we aimed...
18.
Hausburg F, Muller P, Voronina N, Steinhoff G, David R
J Vis Exp
. 2018 Jul;
(136).
PMID: 29985305
While CD133 hematopoietic stem cells (SCs) have been proven to provide high potential in the field of regenerative medicine, their low retention rates after injection into injured tissues as well...
19.
Klopsch C, Skorska A, Ludwig M, Lemcke H, Maass G, Gaebel R, et al.
Dis Model Mech
. 2018 May;
11(6).
PMID: 29752300
Ischemic heart failure is the leading cause of mortality worldwide. An early boost of intracardiac regenerative key mechanisms and angiogenetic niche signaling in cardiac mesenchymal stem cells (MSCs) could improve...
20.
Lemcke H, Voronina N, Steinhoff G, David R
Stem Cells Int
. 2018 Mar;
2018:1909346.
PMID: 29535769
During the past decades, stem cell-based therapy has acquired a promising role in regenerative medicine. The application of novel cell therapeutics for the treatment of cardiovascular diseases could potentially achieve...